MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-GJ-01-0076105
Ampligene India Biotech Private Limited - machinery and equipment in Ahmedabad, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹53.85 Lakh
▼ 24% YoY
Net profit · FY 2025
₹66,477
Net margin 1.2%
EBITDA · FY 2025
₹5.28 Lakh
EBITDA margin 9.8%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Company age
14 yrs
Est. 2012
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered
About Ampligene India Biotech Private Limited
Data last updated:
Ampligene India Biotech Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the industrial machinery retail and distribution segment of the machinery and industrial equipment sector. It was incorporated on 18 September 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U52100GJ2012PTC072019. Its GSTIN is 24AAKCA9460D1ZQ (Gujarat).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Nirupama Ramkrishna Pandya and Deepal Pandya.
Its last annual general meeting (AGM) was held on 20 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Ahmedabad, Gujarat.
As per the financials filed for FY 2025, the company reported a revenue of ₹53.85 Lakh, a decline of 24% compared to the previous year. For the same year it recorded a net profit of ₹66,477 (net margin 1.2%) and EBITDA of ₹5.28 Lakh (EBITDA margin 9.8%). Revenue has declined at a compounded annual rate (CAGR) of 43% over three years and 5% over five years.
The company is associated with 1 brand: AmpliGene India Biotech. Court records list 1 case involving the company, including 1 filed against it. The company has 1 deal on record (1 funding round), with disclosed funding of ₹9 Lakh; the latest was in January 2020.
Ampligene India Biotech Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0076105). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ampligeneindia.com.
Company details
CIN U52100GJ2012PTC072019
Registration Number 072019
Incorporation Date 18 September 2012
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 20 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-GJ-01-0076105
Key People
Nirupama Ramkrishna Pandya Director Deepal Pandya Director Chirag Ramkrishna Pandya Director Recognitions & Rankings of Ampligene India Biotech
Contact details
Ampligene India Biotech Private Limited's registered office is in Ahmedabad, Gujarat. Its website is ampligeneindia.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address4th F/401 Ashwamegh Elegance – 2 Nr Chhabada Building Near Central Mall A, Mbawadi, Ahmedabad, Gujarat, India – 380006
- IndustryMachinery and Equipment, Industrial Machinery Retail & Distribution
To see the full contact details of Ampligene India Biotech Private Limited, buy the company report.
Comprehensive company report
Ampligene India Biotech Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Ampligene India Biotech operates one associated brand: AmpliGene India Biotech. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Isothermal nucleic acid amplification systems are developed for pathogen detection. | ampligeneindia.com |
Business activity
The main business activity of Ampligene India Biotech is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Ampligene India Biotech Private Limited, buy the company report.
Financials of Ampligene India Biotech Private Limited
FY 2024 filings availableAmpligene India Biotech Private Limited reported revenue of ₹53.85 Lakh (down 24% YoY) for FY 2025.
Revenue · FY 2025
₹53.85 Lakh ▼ 24%
Net profit · FY 2025
₹66,477 margin 1.2%
EBITDA · FY 2025
₹5.28 Lakh margin 9.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 24%
3 years · compounded
▼ 43%
5 years · compounded
▼ 5%
EBITDA CAGR growth
1 year
▲ 94%
3 years · compounded
▼ 7%
5 years · compounded
▲ 3%
Revenue has declined at a compounded annual rate (CAGR) of 5% over five years, including a 24% fall in the latest year. EBITDA rose 94% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.28 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹66,477 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.8% | ||||
| Net Profit Margin | 1.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ampligene India Biotech Private Limited, buy the company report.
Board of directors of Ampligene India Biotech Private Limited
Ampligene India Biotech has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nirupama Ramkrishna Pandya | Director | 18 Sep 2012 | 14 Years 1 Months | Current |
| Deepal Pandya Also directs: Ampligene Diagnostics Private Limited | Director | 08 Dec 2012 | 13 Years 11 Months | Current |
| Chirag Ramkrishna Pandya Also directs: Ampligene Diagnostics Private Limited | Director | 17 Jul 2018 | 8 Years 3 Months | Current |
Auditor
Ampligene India Biotech Private Limited is audited by KEYUR BAVISHI & CO. for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KEYUR BAVISHI & CO. | FY 2022 | 131191W |
Shareholding
The shareholding of Ampligene India Biotech Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Ampligene India Biotech Private Limited, buy the company report.
Deals & funding
Ampligene India Biotech Private Limited has 1 deal on record (1 funding round), with disclosed funding of ₹9 Lakh; the latest was in January 2020.
Total deals
1
Funding round
1
Disclosed funding
₹9 Lakh
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jan 2020 | Funding round | ₹9 Lakh | Investors: 3 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Ampligene India Biotech Private Limited has 1 court case on record: 1 filed against it. All case is disposed. Status as checked on 29 Sep 2026.
Total cases
1
Filed against the company
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Kerala | Court case (MFA) | Filed against the company by The Oriental Insurance Company Limited | Disposed |
To see the full case history of Ampligene India Biotech Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ampligene India Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ampligene India Biotech has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAKCA9460D1ZQ | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Ampligene India Biotech Private Limited, buy the company report.
Recent activity
Ampligene India Biotech Private Limited has 5 board changes on record since 2012: 3 appointments and 2 cessations. The latest: Megha Devnani Jitendra ceased to be Director on 21 Aug 2019.
AGM
Ampligene India Biotech Private Limited last Annual general meeting of members was held on 20 Sep 2024 as per latest MCA records.
Filing
Ampligene India Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad.
Ceased
Megha Devnani Jitendra ceased to be Director.
Ceased
Chirag Ramkrishna Pandya ceased to be Additional Director.
Appointed
Chirag Ramkrishna Pandya was appointed as Director.
Appointed
Deepal Pandya was appointed as Director.
Appointed
Nirupama Ramkrishna Pandya was appointed as Director.
Incorporation
18 Sep 2012
Ampligene India Biotech Private Limited was registered on 18 Sep 2012 with Roc Ahmedabad & aged 14 years 1 month as per MCA records.
Frequently asked questions
Ampligene India Biotech is an active private limited company based in Ahmedabad, Gujarat, India. The company works in industrial machinery retail and distribution, within the machinery and equipment industry. It was incorporated on 18 September 2012 (14+ years old) and is registered under CIN U52100GJ2012PTC072019.
Ampligene India Biotech has 3 current directors:
- Nirupama Ramkrishna Pandya - Director
- Deepal Pandya - Director
- Chirag Ramkrishna Pandya - Director
The latest financial statements of Ampligene India Biotech on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 20 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Ampligene India Biotech is 24AAKCA9460D1ZQ, registered in Gujarat.
The CIN (Corporate Identification Number) of Ampligene India Biotech is U52100GJ2012PTC072019. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ampligene India Biotech has 1 court case on record: 1 filed against it.
Ampligene India Biotech was incorporated on 18 September 2012, making it 14+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Ampligene India Biotech has 1 deal on record (1 funding round), with disclosed funding of ₹9 Lakh; the latest was in January 2020.
Megha Devnani Jitendra ceased to be Director on 21 Aug 2019. Chirag Ramkrishna Pandya ceased to be Additional Director on 29 Sep 2018. Chirag Ramkrishna Pandya was appointed as Director on 17 Jul 2018. Ampligene India Biotech has 5 board changes on record in total.
Yes, Ampligene India Biotech is registered as a micro enterprise under Udyam registration (number: UDYAM-GJ-01-0076105).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages